EQUILIBRE BIOPHARMACEUTICALS CORP.

Profile

Company Names

EQUILIBRE BIOPHARMACEUTICALS CORP.

Addresses

430 E 29TH ST., NEW YORK, NY 10016

300 EAST 33RD STREET, APT 14 M, NEW YORK, NY 10016

Phone Numbers

(332) 400-0300
212-308-6000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$47,702,316.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-11-16 
$6,000,002.00 
$6,000,002.00 
$0.00 
Equity 
2
2022-01-14 
$15,902,341.00 
$25,000,000.00 
$9,097,659.00 
Equity 
1
2020-11-04 
$25,799,973.00 
$35,799,973.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PHILIP 
 
BARACH 
DIRECTOR
TCW SPECIAL MORTGAGE CREDITS FUND III (CAYMAN), L.P.   |  TCW SPECIAL MORTGAGE CREDITS FUND III, L.P.   |  UST/TCW SENIOR MORTGAGE SECURITIES FUND, L.P.   |  DOUBLELINE OPPORTUNISTIC CMBS/CRE FUND, L.P.   |  DOUBLELINE CRE FINANCE LLC   |  GRAVITON BIOSCIENCE CORP   |  EQUILIBRE BIOPHARMACEUTICALS CORP.   |  STANDARD BIOCARBON CORP
PHILIP 
A. 
BARACH 
EXECUTIVE OFFICER, DIRECTOR
TCW/STRATEGIC MBS OPPORTUNITIES FUND, L.P.   |  TCW STRATEGIC MBS FUND III, LP   |  EQUILIBRE BIOPHARMACEUTICALS CORP.
DAVID 
 
FRIEDMAN 
DIRECTOR
EPIC BURGER INC   |  LOUISVILLE PROPERTIES I, LLC   |  GREENSBORO PROPERTIES I, LLC   |  MRE MAP, INC.   |  SMALL BAY INDUSTRIAL SRG LLC   |  GENPREX, INC.   |  HERO NETWORK, INC.   |  PANTHER MICRO OPPORTUNITY FUND I, LLC   |  REDWOOD MANAGEMENT HOLDINGS, LLC   |  VIVIDGRO, INC.   |  EPIC BURGER, INC.   |  KNOX HOLDING CORP.   |  CASTERS HOLDINGS INC   |  EQUILIBRE BIOPHARMACEUTICALS CORP.   |  BROOKMONT REAL ESTATE, LP   |  HEMOSHEAR THERAPEUTICS, INC.   |  AGTECH HOLDINGS, INC.   |  PKLYN ONE HOLDINGS LLC   |  CLICK THERAPEUTICS, INC.   |  VERADERMICS, INC
STEVEN 
 
GORDON 
EXECUTIVE OFFICER, DIRECTOR
LILY POND CURRENCY PLUS FUND, LTD.   |  LILY POND CURRENCY FUND LTD   |  LILY POND INVESTORS LTD   |  REFINERY 29 INC.   |  EQUILIBRE BIOPHARMACEUTICALS CORP.   |  GRAVITON BIOSCIENCE CORP
STEVEN 
N. 
GORDON 
EXECUTIVE OFFICER, DIRECTOR
EQUILIBRE BIOPHARMACEUTICALS CORP.
FRANCOIS 
 
MAISONROUGE 
DIRECTOR
EQUILIBRE BIOPHARMACEUTICALS CORP.
JOEL 
 
MARCUS 
DIRECTOR
INTRA CELLULAR THERAPIES INC   |  SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  YUMANITY HOLDINGS, LLC   |  APOGEN BIOTECHNOLOGIES, INC.   |  BORAGEN, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  APPLIED THERAPEUTICS INC.   |  VINDARA, INC.   |  MAGNOLIA NEUROSCIENCES CORP   |  FREQUENCY THERAPEUTICS, INC.   |  EQUILIBRE BIOPHARMACEUTICALS CORP.   |  ARE-WINTER STREET REIT, LLC   |  ARE-MA REGION NO. 102 REIT, LLC   |  ALTPEP CORP   |  ARE-MA REGION NO. 107 REIT, LLC   |  TREX HOLDINGS INC.
CHRISTINA 
 
RAMIREZ 
DIRECTOR
EQUILIBRE BIOPHARMACEUTICALS CORP.
PETER 
 
SIMON 
DIRECTOR
WW NORTON + CO INC   |  ALTUS EQUITY GROUP INC.   |  EQUILIBRE BIOPHARMACEUTICALS CORP.   |  DOMINIUM ADVISORS, INC.   |  BE YOUR BEST, INC.   |  COLORADO BATHHOUSE LLC
PETER 
M. 
SIMON 
DIRECTOR
EQUILIBRE BIOPHARMACEUTICALS CORP.
CHRISTOPHER 
 
THORN 
EXECUTIVE OFFICER, DIRECTOR
EQUILIBRE BIOPHARMACEUTICALS CORP.
SAM 
 
WAKSAL 
EXECUTIVE OFFICER
EQUILIBRE BIOPHARMACEUTICALS CORP.
SAMUEL 
 
WAKSAL 
EXECUTIVE OFFICER, DIRECTOR
GRAVITON BIOSCIENCE CORP   |  EQUILIBRE BIOPHARMACEUTICALS CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-16 
2022-12-01
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-16 
2022-01-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-14 
2020-11-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#